SonarMed

company

About

SonarMed develops technology to improve the placement and monitoring of endotracheal tubes used in patients who cannot breathe on their own.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$3M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

SonarMed was founded in 2005 to commercialize technology licensed from Purdue University to improve the placement and monitoring of endotracheal (breathing) tubes (also known as ETTs or artificial airways) which are used in patients who cannot breathe on their own. The technology was initially developed at Purdue University by SonarMed founders Jeffrey Mans-field, Eduardo Juan and George Wodicka, using the principles of acoustic reflectometry in tubes to provide the medical community with a more comprehensive approach to assist in the maintenance of breathing tubes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3M
SonarMed has raised a total of $3M in funding over 2 rounds. Their latest funding was raised on Oct 24, 2017 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 24, 2017 Series C $3M 1 South Coast Angel Network Detail

Investors

Number of Lead Investors
Number of Investors
1
1
SonarMed is funded by 1 investors. South Coast Angel Network are the most recent investors.
Investor Name Lead Investor Funding Round
South Coast Angel Network Yes Series C